Clinical Trial Update: Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia [Phase 4]

View source ↗

Summary

A Phase 4 trial update reporting completion of a study evaluating repositioning a second-line therapy for chronic immune thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Snippet

Sponsor: Assiut University | Conditions: Immune Thrombocytopenia | Phase 4 | Status: COMPLETED